Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




New FDA Orphan Drugs: CDX-110, ATryn, ISIS 333611
Link ID 1823
Title New FDA Orphan Drugs: CDX-110, ATryn, ISIS 333611
Url http://www.medscape.com/viewarticle/567860?src=rss
Description The FDA has granted orphan drug designation to CDX-110 for the treatment of glioblastoma multiforme, ATryn for the treatment of hereditary antithrombin deficiency, and ISIS 333611 for the treatment of amyotrophic lateral sclerosis. Medscape Medical News
Category Articles > Internal Medicine
Keywords
Date Dec 22, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Internal Medicine
1. Ten Years After: PDE-5 Inhibitors at the End of a Decade
  Dr. Culley Carson offers his thoughts on the 10th year anniversary of the introduction of PDE-5 inhibitors, including the use of these agents in indications other than erectile dysfunction.
Medscape Urology
Category:   Articles > Internal Medicine


2. Preexisting Depression Influences Discharge Destination After Acute Stroke
  Preexisting depression at hospital admission for acute stroke increases the likelihood that a patient will be discharged to institutional care, according to a report in the January issue of Stroke. Reuters Health Information
Category:   Articles > Internal Medicine


3. Pneumothorax a Common Complication of Thoracentesis
  More than 5% of thoracentesis procedures lead to pneumothorax, a meta-analysis indicates. Reuters Health Information
Category:   Articles > Internal Medicine


4. VTE Increases Risk of Arterial CV Events
  A Danish study reports that patients with venous thromboembolism have an increased risk for subsequent arterial cardiovascular events, such as myocardial infarction and stroke. Medscape Medical News
Category:   Articles > Internal Medicine


5. Hyaluronic Acid No Better Than Placebo in Hip Osteoarthritis
  In this randomized controlled trial, 1 intraarticular injection of hyaluronic acid was no more effective than placebo in alleviating the symptoms of hip osteoarthritis. The result refutes an earlier finding from an uncontrolled study that suggested a single shot of the agent could be an effective therapy. Medscape Medical News
Category:   Articles > Internal Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS